NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.

Autor: Schaeffer E; 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Srinivas S; 2Stanford Cancer Institute., Antonarakis ES; 3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Armstrong AJ; 4Duke Cancer Institute., Bekelman JE; 5Abramson Cancer Center at the University of Pennsylvania., Cheng H; 6Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., D'Amico AV; 7Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center., Davis BJ; 8Mayo Clinic Cancer Center., Desai N; 9UT Southwestern Simmons Comprehensive Cancer Center., Dorff T; 10City of Hope National Cancer Center., Eastham JA; 11Memorial Sloan Kettering Cancer Center., Farrington TA; 12Prostate Health Education Network (PHEN)., Gao X; 7Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center., Horwitz EM; 13Fox Chase Cancer Center., Ippolito JE; 14Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Kuettel MR; 15Roswell Park Comprehensive Cancer Center., Lang JM; 16University of Wisconsin Carbone Cancer Center., McKay R; 17UC San Diego Moores Cancer Center., McKenney J; 18Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Netto G; 19O'Neal Comprehensive Cancer Center at UAB., Penson DF; 20Vanderbilt-Ingram Cancer Center., Pow-Sang JM; 21Moffitt Cancer Center., Reiter R; 22UCLA Jonsson Comprehensive Cancer Center., Richey S; 23St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Roach Iii M; 24UCSF Helen Diller Family Comprehensive Cancer Center., Rosenfeld S; 25University of California San Francisco Patient Services Committee Chair., Shabsigh A; 26The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Spratt DE; 27University of Michigan Rogel Cancer Center., Teply BA; 28Fred & Pamela Buffett Cancer Center., Tward J; 29Huntsman Cancer Institute at the University of Utah; and., Shead DA; 30National Comprehensive Cancer Network., Freedman-Cass DA; 30National Comprehensive Cancer Network.
Jazyk: angličtina
Zdroj: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2021 Feb 02; Vol. 19 (2), pp. 134-143. Date of Electronic Publication: 2021 Feb 02.
DOI: 10.6004/jnccn.2021.0008
Abstrakt: The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of recurrent disease are also included. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. This article summarizes the panel's discussions for the 2021 update of the guidelines with regard to systemic therapy for metastatic castration-resistant prostate cancer.
Databáze: MEDLINE